I'm LongbridgeAI, I can summarize articles.Wall Street analysts downgraded several stocks on Tuesday. HSBC downgraded Banco Santander Brasil to Hold with a $6.2 price target. Rosenblatt downgraded Ribbon Communications to Neutral, cutting the target to $2.2. Citizens downgraded Cellectis to Market Perform. Barclays downgraded Scholar Rock to Equal-Weight but raised its target to $58. Raymond James downgraded Ascendis Pharma to Outperform, maintaining a $287 target.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HSBC analyst Carlos Gomez-Lopez downgraded Banco Santander Brasil SA ADR (NYSE:BSBR) from Buy to Hold and cut the price target from $7.2 to $6.2. Banco Santander closed at $5.95 on Monday. See how other analysts view this stock.
- Rosenblatt analyst Mike Genovese downgraded Ribbon Communications Inc (NASDAQ:RBBN) from Buy to Neutral and cut the price target from $3.5 to $2.2. Ribbon Communications shares closed at $2.00 on Monday. See how other analysts view this stock.
- Citizens analyst Silvan Turkcan downgraded Cellectis SA (NASDAQ:CLLS) from Market Outperform to Market Perform. Cellectis closed at $1.83 on Monday. See how other analysts view this stock.
- Barclays analyst Etzer Darout downgraded Scholar Rock Holding Corp (NASDAQ:SRRK) from Overweight to Equal-Weight and raised the price target from $55 to $58. Scholar Rock shares closed at $51.85 on Monday. See how other analysts view this stock.
- Raymond James analyst Martin Auster downgraded Ascendis Pharma A/S (NASDAQ:ASND) from Strong Buy to Outperform and maintained the price target of $287. Ascendis Pharma closed at $264.92 on Monday. See how other analysts view this stock.
Considering buying CLLS stock? Here’s what analysts think:
Photo via Shutterstock
Login to unlock712characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.